Overview

Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits

Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
Neovascularization Induced by Mechanical Barrier disrUption and Systemic erythropoietin in patients with cerebral perfusion deficits (NIMBUS trial)
Phase:
Phase 2
Details
Lead Sponsor:
Ajou University School of Medicine
Collaborators:
Dong-A Pharmaceutical Co., Ltd.
Dong-A ST Co., Ltd.
Treatments:
Epoetin Alfa